Go Back
BioXcel Therapeutics, Inc. reports $57.8 million Q1 profit
By USInMinutes - May 08, 2023, 10:49 AM ET
Last Updated - Jul 18, 2023, 03:34 PM EDT
The company generated $0.21 million in quarterly revenue
BioXcel Therapeutics, Inc. [BTAI] has reported fiscal Q1 profit of $57.80 million.
On a per-share basis, the DE based company said its diluted earnings are $1.84.
The Pharmaceutical Preparations firm posted revenue of $0.21 million in this period.
Also Read:
- BioXcel Therapeutics Reports First Quarter 2023 Financial Results and Recent Operational Highlights
- BioXcel Therapeutics to Present at the BofA Securities 2023 Health Care Conference
- BioXcel Therapeutics to Report First Quarter 2023 Financial Results on May 8, 2023
- OnkosXcel Therapeutics Announces Confidential Submission of Draft Registration Statement for ...
- OnkosXcel Therapeutics Announces Confidential Submission of Draft Registration Statement for ...
NewsInMinutes is an offering of 10kInfo, Inc., bringing you news on the latest regulatory filings. You may subscribe to news alerts here.
Sponsored
Sponsored
Read More from Investing
Popular News
Latest News